|
General Information
|
|
|
Product
|
ENT1 Peptide
|
|
Description
|
Antigenic Blocking Peptide Equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter ENT1
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid reigon 410-460 on mouse Equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter ENT1 protein.
|
|
Accession #
|
GenBank: AAF64035.2
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q9JIM1
|
|
Overview
|
Mediates both influx and efflux of nucleosides across the membrane (equilibrative transporter). It is sensitive (ES) to low concentrations of the inhibitor nitrobenzylmercaptopurine riboside (NBMPR) and is sodium-independent. It has a higher affinity for adenosine. Resistant to dipyridamole and dilazep inhibition (anticancer chemotherapeutics drugs).
|
|
Molecular Function
|
Nucleoside transmembrane transporter activity
|
|
Subcellular Location
|
Cell membrane; Basolateral cell membrane; Apical cell membrane
|
|
Expression
|
Highly expressed in heart, spleen, lung, liver and testis. Lower level of expression in brain and kidney.
|
|
Structure
|
Belongs to the SLC29A/ENT transporter (TC 2.A.57) family.
|
|
Alternative Nomenclature
|
Equilibrative NBMPR-sensitive nucleoside transporter antibody
Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter antibody
Equilibrative nucleoside transporter 1 antibody
es-type antibody
Nucleoside transporter, es-type antibody
Slc29a1 antibody
solute carrier family 29 (equilibrative nucleoside transporter), member 1 antibody
Solute carrier family 29 member 1 antibody
|
| |
|
ENT1 Antibody
ENT1 Antibody BIOTIN
ENT1 Antibody FITC
ENT1 Positive Control
